Skip to Main Content

Paper Details

Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
Cancer Discov
612
2017
-D cultures, Cancer, cancer, colon cancers, genes, patient, patients, tumor, tumor organoids, tumor-derived cells, tumor-derived organoid cultures, uterine malignancies
Author NameAffiliation
Chantal PauliEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Chantal Pauli
Chantal PauliInstitute of Pathology and Molecular Pathology, University Hospital Zurich
Davide PrandiCenter for Integrative Biology, University of Trento
Davide PrandiCenter for Integrative Biology, University of Trento
Andrea SbonerEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Andrea SbonerInstitute for Computational Biomedicine
Andrea SbonerMeyer Cancer Center
Andrea SbonerEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Andrea SbonerMeyer Cancer Center
Andrea SbonerInstitute for Computational Biomedicine
Verena SailerEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Verena Sailer
Loredana PucaEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Terra J McNaryEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Cynthia CheungEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
David J PisapiaEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
David J Pisapia
Rema RaoEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Rema Rao
Juan Miguel MosqueraEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Juan Miguel Mosquera
Juan Miguel MosqueraEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Juan Miguel Mosquera
Brian D RobinsonEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Brian D Robinson
Bishoy M FaltasEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Bishoy M Faltas
Brady Bernard
Olivier ElementoEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Olivier ElementoInstitute for Computational Biomedicine
Olivier ElementoMeyer Cancer Center
Olivier ElementoEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Olivier ElementoMeyer Cancer Center
Olivier ElementoInstitute for Computational Biomedicine
Himisha BeltranEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Himisha Beltran
Himisha BeltranEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Himisha Beltran
Francesca DemichelisEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Francesca DemichelisCenter for Integrative Biology, University of Trento
Francesca DemichelisEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Francesca DemichelisCenter for Integrative Biology, University of Trento
Lewis C CantleyMeyer Cancer Center
Mark A RubinEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Mark A Rubin
Mark A RubinMeyer Cancer Center
Mark A RubinEnglander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian Hospital
Mark A Rubin
Mark A RubinMeyer Cancer Center
  • 1 - 50

Datasets